BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 14730019)

  • 1. eIF4A3 is a novel component of the exon junction complex.
    Chan CC; Dostie J; Diem MD; Feng W; Mann M; Rappsilber J; Dreyfuss G
    RNA; 2004 Feb; 10(2):200-9. PubMed ID: 14730019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing remodels messenger ribonucleoprotein architecture via eIF4A3-dependent and -independent recruitment of exon junction complex components.
    Zhang Z; Krainer AR
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11574-9. PubMed ID: 17606899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CWC22-dependent pre-mRNA splicing and eIF4A3 binding enables global deposition of exon junction complexes.
    Steckelberg AL; Altmueller J; Dieterich C; Gehring NH
    Nucleic Acids Res; 2015 May; 43(9):4687-700. PubMed ID: 25870412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome-wide modulation of splicing by the exon junction complex.
    Wang Z; Murigneux V; Le Hir H
    Genome Biol; 2014; 15(12):551. PubMed ID: 25476502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the Y14-Magoh core of the exon junction complex.
    Lau CK; Diem MD; Dreyfuss G; Van Duyne GD
    Curr Biol; 2003 May; 13(11):933-41. PubMed ID: 12781131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the breast cancer protein MLN51 with the exon junction complex via its speckle localizer and RNA binding module.
    Degot S; Le Hir H; Alpy F; Kedinger V; Stoll I; Wendling C; Seraphin B; Rio MC; Tomasetto C
    J Biol Chem; 2004 Aug; 279(32):33702-15. PubMed ID: 15166247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eIF4A3 Phosphorylation by CDKs Affects NMD during the Cell Cycle.
    Ryu I; Won YS; Ha H; Kim E; Park Y; Kim MK; Kwon DH; Choe J; Song HK; Jung H; Kim YK
    Cell Rep; 2019 Feb; 26(8):2126-2139.e9. PubMed ID: 30784594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hierarchy of exon-junction complex assembly by the spliceosome explains key features of mammalian nonsense-mediated mRNA decay.
    Gehring NH; Lamprinaki S; Hentze MW; Kulozik AE
    PLoS Biol; 2009 May; 7(5):e1000120. PubMed ID: 19478851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the targeting spectrum of rocaglates among eIF4A homologs.
    Naineni SK; Cencic R; Robert F; Brown LE; Haque M; Scott-Talib J; Sénéchal P; Schmeing TM; Porco JA; Pelletier J
    RNA; 2023 Jun; 29(6):826-835. PubMed ID: 36882295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of human eIF4AIII identifies regions necessary for exon junction complex formation and nonsense-mediated mRNA decay.
    Shibuya T; Tange TØ; Stroupe ME; Moore MJ
    RNA; 2006 Mar; 12(3):360-74. PubMed ID: 16495234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core.
    Tange TØ; Shibuya T; Jurica MS; Moore MJ
    RNA; 2005 Dec; 11(12):1869-83. PubMed ID: 16314458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Characterization of a Eukaryotic Initiation Factor 4A-3-Selective Inhibitor That Suppresses Nonsense-Mediated mRNA Decay.
    Iwatani-Yoshihara M; Ito M; Ishibashi Y; Oki H; Tanaka T; Morishita D; Ito T; Kimura H; Imaeda Y; Aparicio S; Nakanishi A; Kawamoto T
    ACS Chem Biol; 2017 Jul; 12(7):1760-1768. PubMed ID: 28440616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay.
    Shibuya T; Tange TØ; Sonenberg N; Moore MJ
    Nat Struct Mol Biol; 2004 Apr; 11(4):346-51. PubMed ID: 15034551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short conserved motif in ALYREF directs cap- and EJC-dependent assembly of export complexes on spliced mRNAs.
    Gromadzka AM; Steckelberg AL; Singh KK; Hofmann K; Gehring NH
    Nucleic Acids Res; 2016 Mar; 44(5):2348-61. PubMed ID: 26773052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The exon junction core complex is locked onto RNA by inhibition of eIF4AIII ATPase activity.
    Ballut L; Marchadier B; Baguet A; Tomasetto C; Séraphin B; Le Hir H
    Nat Struct Mol Biol; 2005 Oct; 12(10):861-9. PubMed ID: 16170325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the exon junction complex components in the central nervous system: a mini review.
    Bartkowska K; Tepper B; Turlejski K; Djavadian RL
    Rev Neurosci; 2018 Nov; 29(8):817-824. PubMed ID: 29791316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Physiological Roles of the Exon Junction Complex in Development and Diseases.
    Asthana S; Martin H; Rupkey J; Patel S; Yoon J; Keegan A; Mao Y
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators.
    Michelle L; Cloutier A; Toutant J; Shkreta L; Thibault P; Durand M; Garneau D; Gendron D; Lapointe E; Couture S; Le Hir H; Klinck R; Elela SA; Prinos P; Chabot B
    Mol Cell Biol; 2012 Mar; 32(5):954-67. PubMed ID: 22203037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific Y14 domains mediate its nucleo-cytoplasmic shuttling and association with spliced mRNA.
    Kataoka N; Diem MD; Yoshida M; Hatai C; Dobashi I; Dreyfuss G; Hagiwara M; Ohno M
    Sci Rep; 2011; 1():92. PubMed ID: 22355610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of the spliceosome subunit SF3b triggers exon junction complex-independent nonsense-mediated decay.
    Carvalho T; Martins S; Rino J; Marinho S; Carmo-Fonseca M
    J Cell Sci; 2017 May; 130(9):1519-1531. PubMed ID: 28302904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.